Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
On the path to 2025: understanding the Alzheimer's disease continuum.
Alzheimers Res Ther. 2017 Aug 9;9(1):60. doi: 10.1186/s13195-017-0283-5.
Alzheimers Res Ther. 2017.
PMID: 28793924
Free PMC article.
Review.
Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology.
Bloudek B, Wirtz HS, Hepp Z, Timmons J, Bloudek L, McKay C, Galsky MD.
Bloudek B, et al.
Clin Epidemiol. 2022 Nov 14;14:1375-1386. doi: 10.2147/CLEP.S377093. eCollection 2022.
Clin Epidemiol. 2022.
PMID: 36404878
Free PMC article.
Time-varying incidence, treatment patterns, treatment rates, and treatment pathways are specified by year to account for guideline-directed changes in standard of care and real-world trends, as well as newly approved clinical treatments. ...
Time-varying incidence, treatment patterns, treatment rates, and treatment pathways are specified by year to account for guideline-di …
Item in Clipboard
Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Staquicini DI, Tang FHF, Markosian C, Yao VJ, Staquicini FI, Dodero-Rojas E, Contessoto VG, Davis D, O'Brien P, Habib N, Smith TL, Bruiners N, Sidman RL, Gennaro ML, Lattime EC, Libutti SK, Whitford PC, Burley SK, Onuchic JN, Arap W, Pasqualini R.
Staquicini DI, et al.
bioRxiv [Preprint]. 2021 Mar 16:2021.03.15.435496. doi: 10.1101/2021.03.15.435496.
bioRxiv. 2021.
PMID: 33758865
Free PMC article.
Updated.
Preprint.
As proof-of-concept preclinical experiments, we show that targeted phage- and AAVP-based particles serve as robust yet versatile enabling platforms for ligand-directed immunization and promptly yield COVID-19 vaccine prototypes for further translational development. SIGNIFICANCE: …
As proof-of-concept preclinical experiments, we show that targeted phage- and AAVP-based particles serve as robust yet versatile enabling pl …
Item in Clipboard
Cite
Cite